CNR2 and neoplasm: We then investigated whether pharmacological blockade of CB receptors in tumor-bearing C57BL/6J mice could replicate findings obtained in knockout mice using previously tested doses of CB1 antagonist SR141716 (28, 29) and CB2 antagonist SR144528 (29, 30).